Prevalence, duration, and clinical implications of Continuous Glucose Monitor (CGM) measurement limit capping in type 1 diabetes.

Allbwn ymchwil: Cyfraniad at gyfnodolyn › Erthygl › adolygiad gan gymheiriaid

Iaith wreiddiol	Saesneg
Rhif yr erthygl	e70412
Cyfnodolyn	Diabetic Medicine
Dyddiad ar-lein cynnar	2 Gorff 2026
Dynodwyr Gwrthrych Digidol (DOIs)	https://doi.org/10.1111/dme.70412
Statws	E-gyhoeddi cyn argraffu - 2 Gorff 2026

NDC y CU

Mae’r allbwn hwn yn cyfrannu at y Nod(au) Datblygu Cynaliadwy canlynol

CGM_cap_DiabeticMedicine_revision_2_cleaned
Llawysgrif awdur wedi’i dderbyn, 382 KB
Embargo yn dod i ben: 02/07/2027 00:00 BST

@article{61251addbcb6491e93410f40d59729cf,

title = "Prevalence, duration, and clinical implications of Continuous Glucose Monitor (CGM) measurement limit capping in type 1 diabetes.",

author = "John Mulley",

year = "2026",

month = jul,

day = "2",

doi = "10.1111/dme.70412",

language = "English",

journal = "Diabetic Medicine",

issn = "0742-3071",

publisher = "Wiley-Blackwell",

}